• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Annovis Bio Inc (NY: ANVS )

    10.44 -0.89 (-7.82%)
    Streaming Delayed Price Updated: 11:53 AM EDT, Jul 22, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 219,298
    Open 11.48
    Bid (Size) 10.42 (2)
    Ask (Size) 10.47 (5)
    Prev. Close 11.33
    Today's Range 10.37 - 11.54
    52wk Range 4.530 - 22.49
    Shares Outstanding 11,171,480
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Annovis Bio Inc. (NYSE: ANVS) Announces New Data From Phase III Study of Buntanetap for Early Parkinson’s Disease
    Via Investor Brand Network
    Annovis Bio Inc. (NYSE: ANVS) Files New Composition of Matter Patent for Buntanetap
    Via Investor Brand Network
    Topics Intellectual Property
    Exposures Intellectual Property

    Performance

    YTD
    -44.83%
    -44.83%
    1 Month
    +75.83%
    +75.83%
    3 Month
    -9.10%
    -9.10%
    6 Month
    -19.22%
    -19.22%
    1 Year
    -18.40%
    -18.40%

    More News

    Read More
    BioMedNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Secures FDA Approval for New Form of Buntanetap
    Via Investor Brand Network
    Topics Intellectual Property
    Exposures Intellectual Property Product Safety
    Costco To Rally More Than 10%? Here Are 10 Top Analyst Forecasts For Thursday
    Via Benzinga
    Peering Into Annovis Bio's Recent Short Interest
    Via Benzinga
    Why Did Annovis Bio (ANVS) Stock Close Up 80% Today?
    Via InvestorPlace
    Peering Into Annovis Bio's Recent Short Interest
    Via Benzinga
    Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Why NIO Shares Are Trading Lower By Over 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    BioMedNewsBreaks — Annovis Bio Inc. (NYSE: ANVS) Names Four New Members to Executive Team
    Via Investor Brand Network
    What's Going On With Annovis Shares Today?
    Via Benzinga
    Tesla, Paramount Global, Annovis Bio, Eli Lilly, Amazon: Why These 5 Stocks Are On Investors' Radars Today
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    What's Going With Annovis Bio Shares Tuesday?
    Via Benzinga
    BioMedNewsBreaks — Annovis Bio Inc. (NYSE: ANVS) Releases Significant Findings from Phase 3 Parkinson’s Study, Schedules Webcast
    Via Investor Brand Network
    Annovis Bio Inc. (NYSE: ANVS) Announces Results From Phase II/III Buntanetap Study for the Treatment of Alzheimer’s Disease
    Via Investor Brand Network
    BioMedNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Announces Filing of Provisional Patent Covering Manufacturing Process of New Solid Forms of Buntanetap
    Via Investor Brand Network
    Topics Intellectual Property
    Exposures Intellectual Property
    BioMedNewsBreaks — Annovis Bio Inc. (NYSE: ANVS) Submits Patent Application for New Composition of Buntanetap Matter
    Via Investor Brand Network
    Topics Intellectual Property
    Exposures Intellectual Property
    BioMedNewsBreaks — Annovis Bio Inc. (NYSE: ANVS) Announces Upcoming Investor Webcast Focused on PD, Lead Drug Candidate
    Via Investor Brand Network
    BioMedNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Officials to Present Results from Alzheimer’s Study at AAIC 2024
    Via Investor Brand Network
    BioMedNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Announces Results of Recent Alzheimer’s Study, Schedules Investor Call
    Via Investor Brand Network
    Annovis Bio Inc. (NYSE: ANVS) Is ‘One to Watch’
    Via Investor Brand Network
    BioMedNewsBreaks — Annovis Bio Inc. (NYSE: ANVS) Schedules Investor Event Spotlighting Lead Drug Candidate
    Via Investor Brand Network
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    Annovis Announces New Publication in a Peer-Reviewed Journal
    From Annovis Bio Inc.
    Via GlobeNewswire
    INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Annovis Bio, Inc. (ANVS) on Behalf of Investors
    From Law Offices of Howard G. Smith
    Via Business Wire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.